Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis

Published:2015-11-20 Issue:2 Volume:48 Page:191-199
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Jiang Hui-Ming,Wei Jin-Huan,Zhang Zhi-Ling,Fang Yong,Zhou Bang-Fen,Chen Zhen-Hua,Lu Jun,Liao Bing,Zhou Fang-Jian,Luo Jun-Hang,Chen Wei

Funder

the National Natural Science Foundation of China

Guangdong Provincial Science and Technology Foundation

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11255-015-1161-3.pdf

Reference35 articles.

1. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG et al (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80(5):987–989

2. Lam JS, Leppert JT, Figlin RA, Belldegrun AS (2005) Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 6(1):7–18

3. Capitanio U, Cloutier V, Zini L, Isbarn H, Jeldres C, Shariat SF et al (2009) A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int 103(11):1496–1500

4. Klatte T, Han KR, Said JW, Bohm M, Allhoff EP, Kabbinavar FF et al (2008) Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol Oncol 26(6):604–609

5. Lee WK, Byun SS, Kim HH, Rha KH, Hwang TK, Sung GT et al (2010) Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study. Int J Urol 17(11):898–904

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma;Frontiers in Oncology;2022-11-14

2. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma;Histopathology;2022-06-10

3. Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022;Current Oncology Reports;2022-04-19

4. Renal Mass Biopsy;Techniques in Vascular and Interventional Radiology;2021-12

5. A CT-based radiomics nomogram for differentiation of small masses (< 4 cm) of renal oncocytoma from clear cell renal cell carcinoma;Abdominal Radiology;2021-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3